advertisement
Wang X 9
Showing records 1 to 9 | Display all abstracts from Wang X100339 Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
Xi X
Annals of translational medicine 2022; 10: 312
100618 NEDD9 Mediates the FAK/Src Signaling Pathway to Promote the Adhesion of Human Trabecular Meshwork Cells after Dexamethasone Treatment
Tan S
Current Eye Research 2022; 0: 1-9
100339 Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
Chen Q
Annals of translational medicine 2022; 10: 312
100618 NEDD9 Mediates the FAK/Src Signaling Pathway to Promote the Adhesion of Human Trabecular Meshwork Cells after Dexamethasone Treatment
Wang P; Hu J
Current Eye Research 2022; 0: 1-9
100339 Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
Ma J
Annals of translational medicine 2022; 10: 312
100618 NEDD9 Mediates the FAK/Src Signaling Pathway to Promote the Adhesion of Human Trabecular Meshwork Cells after Dexamethasone Treatment
Wang X
Current Eye Research 2022; 0: 1-9
100339 Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
Wang X; Xia Y
Annals of translational medicine 2022; 10: 312
100618 NEDD9 Mediates the FAK/Src Signaling Pathway to Promote the Adhesion of Human Trabecular Meshwork Cells after Dexamethasone Treatment
Li H
Current Eye Research 2022; 0: 1-9
100339 Acteoside protects retinal ganglion cells from experimental glaucoma by activating the PI3K/AKT signaling pathway via caveolin 1 upregulation
Wen X; Cai B; Li Y
Annals of translational medicine 2022; 10: 312
